CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers and grants	$ 53,886,080	$ 37,232,082
Cash received from insurance receivable	644,389	861,902
Cash paid to suppliers and employees	(63,624,525)	(65,273,967)
Cash paid for operating leases	(1,453,778)	(1,404,532)
Cash paid for finance leases	(17,015)	(20,077)
Interest and taxes, net	(2,129,104)	(2,281,124)
Net cash used in operating activities	(12,693,953)	(30,885,716)
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of and deposits on fixed assets	(1,451,233)	(1,824,285)
Patent application costs	0	(33,398)
Net cash used in investing activities	(1,451,233)	(1,857,683)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net	4,311,486	38,811,958
Proceeds from option exercises	0	85,555
Interest received on Employee Retention Credit	67,818	0
Principal payments for finance leases	(70,514)	(61,867)
Payments on note payable	(900,000)	0
Payments of tax withholding on stock award	(41,537)	(145,225)
Net cash provided by financing activities	3,367,253	38,690,421
Effect of exchange rate changes on cash	184,026	(240,431)
INCREASE IN CASH AND CASH EQUIVALENTS	(10,593,907)	5,706,591
Cash and cash equivalents - beginning of the period	28,772,892	23,066,301
Cash and cash equivalents - end of the period	18,178,985	28,772,892
RECONCILIATION OF NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES:
Net Loss	(23,290,657)	(33,903,529)
Adjustments:
Depreciation and amortization	2,552,969	2,930,976
Share based compensation	2,299,081	2,431,982
Benefit from deferred tax liability	0	(69,941)
Provision for (recovery of) doubtful accounts	103,854	(53,751)
Non-cash inventory changes	569,430	4,054,701
Impairment charges	3,033,565	5,880,741
Changes in assets and liabilities:
Accounts receivable	4,800,838	(8,009,969)
Inventories	4,635,608	(4,458,750)
Prepaid expenses and other current assets	(2,124,366)	(545,305)
Insurance receivable, current	(12,186,322)	0
Deposits and other assets	(76,862)	(234,874)
Insurance receivable, long-term	386,205	(386,205)
Accounts payable and accrued liabilities	6,602,704	3,085,205
Deferred revenue	0	(1,606,997)
Net cash used in operating activities	$ (12,693,953)	$ (30,885,716)